Table 2 Calculation and comparison of age standardised rates (ASRs) for cancers in the control arm, compared to reported general population data
Control survey population | Globocan ASR ^ | Ratio | |||||
|---|---|---|---|---|---|---|---|
Cases | Cases per 100,000 | ASR per 100,000^ | ASR (men) | ASR (women) | ASR if 52% female | Survey ASR/Globocan ASR | |
Bladder | 9 | 319 | 4.1 | 16.3 | 3.6 | 9.7 | 0.43 |
Brain | 21 | 745 | 9.7 | 5.8 | 4.4 | 5.1 | 1.91 |
Breast | 91 | 3230 | 42.0 | 0.0 | 66.4 | 34.5 | 1.22 |
Cervical | 14 | 497 | 6.5 | 0.0 | 9.1 | 4.7 | 1.36 |
Colorectal | 56 | 1988 | 25.8 | 37.7 | 24.3 | 30.7 | 0.84 |
Kidney | 11 | 390 | 5.1 | 11.9 | 5.9 | 8.8 | 0.58 |
Leukemia | 17 | 603 | 7.8 | 9.1 | 5.9 | 7.4 | 1.05 |
Liver | 27 | 958 | 12.4 | 8.2 | 2.7 | 5.3 | 2.33 |
Lung | 106 | 3763 | 48.9 | 47.1 | 18.8 | 32.4 | 1.51 |
Lymphoma | 19 | 674 | 8.8 | 12.5 | 9.0 | 10.7 | 0.82 |
Mouth | 5 | 177 | 2.3 | 6.8 | 2.3 | 4.5 | 0.52 |
Myeloma | 8 | 284 | 3.7 | 3.3 | 2.2 | 2.7 | 1.35 |
Oesophagus | 9 | 319 | 4.1 | 6.5 | 1.3 | 3.8 | 1.09 |
Ovary | 13 | 461 | 6.0 | 0.0 | 9.3 | 4.8 | 1.24 |
Pancreas | 21 | 745 | 9.7 | 8.3 | 5.5 | 6.8 | 1.41 |
Prostate | 56 | 1988 | 25.8 | 61.7 | 0.0 | 29.6 | 0.87 |
Stomach | 39 | 1384 | 18.0 | 16.7 | 7.3 | 11.8 | 1.52 |
Uterus | 20 | 710 | 9.2 | 0.0 | 13.0 | 6.8 | 1.36 |